Bias against biologics in bariatric surgery: is it justified?
Despite higher ASA status, patients on BIA did not have increased postoperative complications, and had similar weight loss to control patients after MBS. Our data suggests that when managed appropriately, patients on BIA have similar benefits from MBS without added risk.
Authors
- Victoria Lyo (ORCID: https://orcid.org/0000-0003-3139-7365)
- Shushmita M Ahmed (ORCID: https://orcid.org/0009-0009-7146-4607)
- Jerome C. Anyalebechi (ORCID: https://orcid.org/0000-0002-7309-3741)
- Mohamed Ali (ORCID: https://orcid.org/0009-0004-5841-6655)
- Brian Howard
Institutions
- University of California Davis Medical Center (US)
- University of California, Davis (US)
Publication Details
- Journal
- Surgical Endoscopy
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1007/s00464-025-12046-z
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00